Jason S. Reingold

Learn More
Despite the increasing prevalence of nonalcoholic fatty liver disease (NAFLD), the criteria used to diagnose the disorder remain poorly defined. Localized proton magnetic resonance spectroscopy (MRS) accurately measures hepatic triglyceride content (HTGC) but has been used only in small research studies. Here, MRS was used to analyze the distribution of(More)
The primary aim of this investigation was to determine the reliability and sensitivity of 1H magnetic resonance spectroscopy (1H-MRS) as a method for quantifying myocardial triglyceride (TG) content in humans over time and in response to metabolic perturbations. Three separate experiments were designed to quantify myocardial TG content 1) over a 90-day(More)
Barbershops constitute potential sites for community health promotion programs targeting hypertension (HTN) in black men, but such programs have not been evaluated previously. Here we conducted 2 nonrandomized feasibility studies to determine whether an enhanced intervention program of continuous blood pressure (BP) monitoring and peer-based health(More)
From the Department of Radiation Oncology, Brigham and Women’s Hospital, and Dana–Farber Cancer Institute (A.K.N.); the Divisions of Medical Oncology (J.S.A.) and Cardiology (J.S.R.), Department of Medicine, and the Departments of Radiology (S.R.D.) and Pathology (J.R.S.), Massachusetts General Hospital; and the Departments of Radiation Oncology (A.K.N.),(More)
Szczepaniak, Lidia S., Pamela Nurenberg, David Leonard, Jeffrey D. Browning, Jason S. Reingold, Scott Grundy, Helen H. Hobbs, and Robert L. Dobbins. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288: E462–E468, 2005. First published August 31,(More)
Reingold, Jason S., Jonathan M. McGavock, Shaheen Kaka, Tommy Tillery, Ronald G. Victor, and Lidia S. Szczepaniak. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289: E935–E939, 2005. First published June 21, 2005;(More)
  • 1